CGAS and neoplasm: Remarkably, cGAS EV-treated mice rejected a rechallenge with MC38 cells on the opposite flank 50 days after recovery from original tumor inoculation, suggesting that cGAS EV administration induces a systemic antitumor response and the formation of antitumor immune memory (Fig. 3F).